Trial Profile
A open-label study assessing the effect of a single administration of ZILRETTA on synovitis in patients with OA of the knee
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 14 May 2018 New trial record
- 08 May 2018 According to a a Flexion Therapeutics media release, the study is expected to enroll over approximately six months and topline results are anticipated in 2019.